NDRG3 and hepatocellular carcinoma: NDRG3 promoted tumor growth and angiogenesis in HCC via signaling through Raf-ERK axis [18], and enhanced HCC metastasis via Wnt/β-catenin signaling by promoting nuclear translocation of β-catenin [7].